Helius Medical Technologies (HSDT) Competitors $0.91 +0.43 (+89.58%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends HSDT vs. PSTV, INBS, TNON, NUWE, POAI, AEMD, CTCX, SINT, STSS, and CHEKShould you be buying Helius Medical Technologies stock or one of its competitors? The main competitors of Helius Medical Technologies include Plus Therapeutics (PSTV), Intelligent Bio Solutions (INBS), Tenon Medical (TNON), Nuwellis (NUWE), Predictive Oncology (POAI), Aethlon Medical (AEMD), Carmell (CTCX), Sintx Technologies (SINT), Sharps Technology (STSS), and Check-Cap (CHEK). These companies are all part of the "medical equipment" industry. Helius Medical Technologies vs. Plus Therapeutics Intelligent Bio Solutions Tenon Medical Nuwellis Predictive Oncology Aethlon Medical Carmell Sintx Technologies Sharps Technology Check-Cap Plus Therapeutics (NASDAQ:PSTV) and Helius Medical Technologies (NASDAQ:HSDT) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, analyst recommendations, community ranking and earnings. Do analysts prefer PSTV or HSDT? Plus Therapeutics presently has a consensus target price of $13.50, indicating a potential upside of 1,138.53%. Helius Medical Technologies has a consensus target price of $24.00, indicating a potential upside of 2,537.36%. Given Helius Medical Technologies' higher probable upside, analysts clearly believe Helius Medical Technologies is more favorable than Plus Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Plus Therapeutics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Helius Medical Technologies 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has stronger earnings & valuation, PSTV or HSDT? Helius Medical Technologies has lower revenue, but higher earnings than Plus Therapeutics. Plus Therapeutics is trading at a lower price-to-earnings ratio than Helius Medical Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPlus Therapeutics$4.91M1.31-$13.32M-$2.53-0.43Helius Medical Technologies$502K6.76-$8.85M-$6.18-0.15 Do institutionals and insiders hold more shares of PSTV or HSDT? 3.3% of Plus Therapeutics shares are owned by institutional investors. Comparatively, 18.6% of Helius Medical Technologies shares are owned by institutional investors. 5.5% of Plus Therapeutics shares are owned by insiders. Comparatively, 5.1% of Helius Medical Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media favor PSTV or HSDT? In the previous week, Helius Medical Technologies had 4 more articles in the media than Plus Therapeutics. MarketBeat recorded 6 mentions for Helius Medical Technologies and 2 mentions for Plus Therapeutics. Helius Medical Technologies' average media sentiment score of 0.25 beat Plus Therapeutics' score of -0.84 indicating that Helius Medical Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Plus Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative Helius Medical Technologies 0 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk and volatility, PSTV or HSDT? Plus Therapeutics has a beta of 0.7, indicating that its stock price is 30% less volatile than the S&P 500. Comparatively, Helius Medical Technologies has a beta of 1.68, indicating that its stock price is 68% more volatile than the S&P 500. Is PSTV or HSDT more profitable? Plus Therapeutics has a net margin of -225.07% compared to Helius Medical Technologies' net margin of -1,764.74%. Plus Therapeutics' return on equity of 0.00% beat Helius Medical Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Plus Therapeutics-225.07% N/A -154.56% Helius Medical Technologies -1,764.74%-244.82%-127.10% Does the MarketBeat Community favor PSTV or HSDT? Plus Therapeutics received 48 more outperform votes than Helius Medical Technologies when rated by MarketBeat users. Likewise, 62.39% of users gave Plus Therapeutics an outperform vote while only 55.56% of users gave Helius Medical Technologies an outperform vote. CompanyUnderperformOutperformPlus TherapeuticsOutperform Votes6862.39% Underperform Votes4137.61% Helius Medical TechnologiesOutperform Votes2055.56% Underperform Votes1644.44% SummaryPlus Therapeutics and Helius Medical Technologies tied by winning 9 of the 18 factors compared between the two stocks. Ad InvestorPlaceWall Street Icon: “You must get on the right side of this thing”I created one of the first quantitative analysis-based stock picking systems long before "quants" became a thing on Wall Street… leading Forbes to call me "King of the Quants." I'm writing to you today because my system has recently uncovered a market phenomenon I haven't seen in 30 years.This market shakeup is going to be much more intense. Get Helius Medical Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for HSDT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSDT vs. The Competition Export to ExcelMetricHelius Medical TechnologiesElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.39M$3.07B$5.14B$9.08BDividend YieldN/A1.75%5.09%4.23%P/E Ratio-0.1517.1690.0517.20Price / Sales6.7650.221,117.09117.04Price / CashN/A39.9143.1037.85Price / Book0.273.724.784.78Net Income-$8.85M$89.83M$120.31M$225.60M7 Day Performance85.71%-1.76%-1.92%-1.23%1 Month Performance102.22%-1.47%13.65%0.46%1 Year Performance-89.15%-0.54%28.34%15.24% Helius Medical Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSDTHelius Medical Technologies2.6361 of 5 stars$0.91+89.6%$24.00+2,537.4%-87.0%$3.39M$502,000.00-0.1530Short Interest ↓Gap UpHigh Trading VolumePSTVPlus Therapeutics1.5574 of 5 stars$1.17-7.9%$13.50+1,054.4%-42.3%$6.90M$4.91M-0.5020INBSIntelligent Bio Solutions1.0388 of 5 stars$1.46-1.4%N/A-68.7%$6.41M$3.19M0.0010Positive NewsTNONTenon Medical1.9628 of 5 stars$1.94-1.0%$5.50+183.5%-0.5%$6.09M$2.93M-0.078Positive NewsNUWENuwellis1.6403 of 5 stars$1.19+0.8%$17.00+1,328.6%-95.0%$5.20M$8.86M-0.0159News CoveragePositive NewsPOAIPredictive Oncology2.2425 of 5 stars$0.73-5.8%$3.00+308.6%-76.7%$4.90M$1.48M-0.2530News CoverageGap UpAEMDAethlon Medical3.0781 of 5 stars$0.35-3.2%$7.00+1,917.3%-69.3%$4.85M$570,000.00-0.1310Analyst ForecastNews CoverageGap UpCTCXCarmell1.2731 of 5 stars$0.21-2.3%N/A-94.5%$4.29M$32,839.000.0014News CoveragePositive NewsSINTSintx Technologies0.4764 of 5 stars$3.02-2.6%N/A-95.3%$4.06M$1.64M-0.0643STSSSharps Technology1.0349 of 5 stars$2.09+2.5%N/AN/A$3.76MN/A-0.253News CoveragePositive NewsCHEKCheck-Cap0.3448 of 5 stars$0.62-1.1%N/A-71.4%$3.63MN/A-0.2180Analyst ForecastNews CoverageGap Down Related Companies and Tools Related Companies PSTV Competitors INBS Competitors TNON Competitors NUWE Competitors POAI Competitors AEMD Competitors CTCX Competitors SINT Competitors STSS Competitors CHEK Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:HSDT) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Helius Medical Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Helius Medical Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.